112 related articles for article (PubMed ID: 38063382)
1. Six Years of Disease-free Survival After a Second Cord Blood Transplantation for Recurrent Acute Lymphocytic Leukemia in a Child With Down Syndrome.
Aoshima M; Yagasaki H; Shimozawa K; Kanezawa K; Ueno M; Morioka I
J Pediatr Hematol Oncol; 2024 Jan; 46(1):e100-e102. PubMed ID: 38063382
[TBL] [Abstract][Full Text] [Related]
2. Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
Kawahara Y; Ishimaru S; Tanaka J; Kako S; Hirayama M; Kanaya M; Ishida H; Sato M; Kobayashi R; Kato M; Goi K; Saito S; Koga Y; Hashii Y; Kato K; Sato A; Atsuta Y; Sakaguchi H
Transplant Cell Ther; 2022 Sep; 28(9):598.e1-598.e8. PubMed ID: 35660064
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
Goto H; Kaneko T; Shioda Y; Kajiwara M; Sakashita K; Kitoh T; Hayakawa A; Miki M; Kato K; Ogawa A; Hashii Y; Inukai T; Kato C; Sakamaki H; Yabe H; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Jan; 62(1):148-52. PubMed ID: 25262825
[TBL] [Abstract][Full Text] [Related]
5. Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
Bachanova V; Weisdorf DJ; Wang T; Marsh SGE; Cereb N; Haagenson MD; Spellman SR; Lee SJ; Guethlein LA; Parham P; Miller JS; Cooley SA
Biol Blood Marrow Transplant; 2019 May; 25(5):949-954. PubMed ID: 30594542
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
Shimoni A; Labopin M; Lorentino F; Van Lint MT; Koc Y; Gülbas Z; Tischer J; Bruno B; Blaise D; Pioltelli P; Afanasyev B; Ciceri F; Mohty M; Nagler A
Leukemia; 2019 Jan; 33(1):230-239. PubMed ID: 29907809
[TBL] [Abstract][Full Text] [Related]
7. [The curative efficacy of unrelated umbilical cord blood stem cells transplantation in intensified myeloablative conditioned patients with acute lymphoblastic leukemia].
Tang B; Zheng C; Liu H; Zhu X; Geng L; Wang X; Ding K; Yao W; Tong J; Song K; Zhang L; Qiang P; Zhang X; Sun Z
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):191-5. PubMed ID: 26926370
[TBL] [Abstract][Full Text] [Related]
8. Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.
Rocha V; Ruggeri A; Spellman S; Wang T; Sobecks R; Locatelli F; Askar M; Michel G; Arcese W; Iori AP; Purtill D; Danby R; Sanz GF; Gluckman E; Eapen M;
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1284-1289. PubMed ID: 27090957
[TBL] [Abstract][Full Text] [Related]
9. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
10. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT; Kennedy-Nasser AA; Kitko C; Kurtzberg J; Lehmann L; O'Brien T; Pulsipher MA; Smith FO; Zhang MJ; Eapen M; Carpenter PA;
Pediatr Blood Cancer; 2014 Jun; 61(6):1126-8. PubMed ID: 24391118
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
12. Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
Yokoyama H; Kanda J; Kawahara Y; Uchida N; Tanaka M; Takahashi S; Onizuka M; Noguchi Y; Ozawa Y; Katsuoka Y; Ota S; Ohta T; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Nakasone H; Morishima S
Bone Marrow Transplant; 2021 Jun; 56(6):1352-1363. PubMed ID: 33420393
[TBL] [Abstract][Full Text] [Related]
13. Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
Koh H; Nakamae H; Hagihara K; Nakane T; Manabe M; Hayashi Y; Nishimoto M; Umemoto Y; Nakamae M; Hirose A; Inoue E; Inoue A; Yoshida M; Bingo M; Okamura H; Aimoto R; Aimoto M; Terada Y; Koh KR; Yamane T; Ohsawa M; Hino M
J Exp Clin Cancer Res; 2011 Apr; 30(1):36. PubMed ID: 21477348
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
Smith AR; Baker KS; Defor TE; Verneris MR; Wagner JE; Macmillan ML
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1086-93. PubMed ID: 19660721
[TBL] [Abstract][Full Text] [Related]
15. Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution.
Lee JH; Yoon HS; Song JS; Choi ES; Moon HN; Seo JJ; Im HJ
J Korean Med Sci; 2009 Oct; 24(5):904-9. PubMed ID: 19794991
[TBL] [Abstract][Full Text] [Related]
16. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.
Willemze R; Rodrigues CA; Labopin M; Sanz G; Michel G; Socié G; Rio B; Sirvent A; Renaud M; Madero L; Mohty M; Ferra C; Garnier F; Loiseau P; Garcia J; Lecchi L; Kögler G; Beguin Y; Navarrete C; Devos T; Ionescu I; Boudjedir K; Herr AL; Gluckman E; Rocha V;
Leukemia; 2009 Mar; 23(3):492-500. PubMed ID: 19151783
[TBL] [Abstract][Full Text] [Related]
17. Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.
Yahng SA; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim HJ
Biol Blood Marrow Transplant; 2016 Feb; 22(2):316-323. PubMed ID: 26415557
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
19. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
20. Autologous Recovery With Chromosomal Abnormalities After Unrelated Umbilical Cord Blood Transplantation With Myeloablative Conditioning in a Case of Pediatric Acute Lymphoblastic Leukemia.
Uchihara Y; Kato I; Hanaki R; Saida S; Iwamoto S; Umeda K; Hiramatsu H; Adachi S; Takita J
J Pediatr Hematol Oncol; 2023 Jan; 45(1):e142-e144. PubMed ID: 36251880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
